IP Library Granted Patent US 7,888,073
Granted Patent B2
US 7,888,073 · App. 12/580,596 · Granted Feb 15, 2011

Method for sequencing nucleic acid molecules

Assignee: Gen-Probe Incorporated
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,888,073
App. No.
12/580,596
Granted
Feb 15, 2011
Kind
B2
Abstract

The sequence of a target polynucleotide can be determined by: (i) contacting the target polynucleotide with a polymerase enzyme and one of the nucleotides A, T(U), G and C under conditions suitable for the polymerase reaction to proceed; (ii) measuring the time taken for the polymerase to bind to and subsequently dissociate from the target polynucleotide, to thereby determine whether the polymerase has incorporated the nucleotide onto the target polynucleotide; (iii) optionally repeating steps (i) and (ii) with additional nucleotides, to thereby identify the sequence of the target polynucleotide.

Claims (26)

1. A method for sequencing a target polynucleotide, comprising:

(i) contacting the target polynucleotide with a polymerase enzyme and one or amore nucleotides selected from the group consisting of A, T (U), G, and C under conditions suitable for a polymerase reaction to proceed, wherein the contact occurs in a flow cell comprising one or more immobilized polynucleotides;

(ii) observing the interaction of the polymerase enzyme with the target polynucleotide in the presence of the one or more nucleotides; and

(iii) measuring the time taken for the polymerase to bind to, and subsequently dissociate from, the target polynucleotide to identify whether the polymerase has incorporated a nucleotide onto a nascent polynucleotide paired with the target polynucleotide, and thereby identify the sequence of the target polynucleotide.

2. The method of claim 1 , wherein the one or more immobilized polynucleotides comprise(s) a primer capable of hybridization with the target polynucleotide.

3. The method of claim 1 , wherein the one or more immobilized polynucleotides comprise(s) the target polynucleotide.

4. The method of claim 1 , wherein the nascent polynucleotide comprises a primer.

5. The method of claim 1 , further comprising repeating steps (i) through (iii) with additional nucleotides.

6. The method of claim 5 , wherein steps (i) through (iii) are carried out with each of the different nucleotides in turn, until incorporation is detected.

7. The method of claim 1 , wherein a plurality of target polynucleotides are immobilized on a support material.

8. The method of claim 1 , wherein step (ii), and optionally step (iii), is carried out by measuring applied radiation.

9. The method of claim 1 , wherein step (ii), and optionally step (iii), is carried out by measuring raman scattering.

10. The method of claim 1 , wherein step (ii), and optionally step (iii), is carried out by applying a surface electromagnetic wave.

11. The method of claim 10 , wherein the surface electromagnetic wave is a surface plasmon wave.

12. The method of claim 1 , wherein step (ii), and optionally step (iii), is carried out by utilizing a non-linear imaging system.

13. The method of claim 12 , wherein the non-linear imaging system relies on second or third harmonic generation imaging.

14. The method of claim 1 , wherein the polymerase comprises a detectable label attached thereto.

15. The method of claim 14 , wherein the label is a fluorophore.

16. The method claim 14 , wherein the polymerase further comprises an energy donor label or an energy acceptor label, and wherein step (ii), and optionally step (iii), is carried out by measuring energy transfer between the fluorophore and the energy donor or acceptor.

17. The method of claim 7 , wherein each of the plurality of target polynucleotides is immobilized in an individual flow cell.

18. The method of claim 17 , wherein each of the flow cells is observed and measured individually.

19. The method of claim 1 , wherein the one or more nucleotides comprise a removable blocking group.

20. The method of claim 19 , wherein the blocking group is removed prior to, or simultaneous with, step (ii).

21. The method of claim 19 , wherein the blocking group is removed via the application of electromagnetic radiation.

22. The method of claim 1 , wherein steps (ii) and (iii) are conducted simultaneously or in sequence.

23. The method of claim 1 , further comprising determining whether a mutation in the target polynucleotide exists by comparing the sequence identification of step (iii) with the native sequence of the target polynucleotide.

Assignments (9)
RELEASE OF SECURITY INTEREST Recorded Apr 28, 2026
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: HOLOGIC, INC., ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO DIRECT RADIOGRAPHY CORP.; CYTYC CORPORATION, ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO BIOLUCENT, LLC; CYTYC SURGICAL PRODUCTS, LLC, AS SUCCESSOR-BY-CONVERSION TO CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; GEN-PROBE INCORPORATED, ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE PRODESSE, INC.; SUROS SURGICAL SYSTEMS, INC.
Reel/Frame 075566/0039 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT PATENT NO. 8081301 PREVIOUSLY RECORDED AT REEL: 028810 FRAME: 0745. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY AGREEMENT. Recorded Nov 9, 2017
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
To: GOLDMAN SACHS BANK USA
Reel/Frame 044432/0565 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT PATENT NO. 8081301 PREVIOUSLY RECORDED AT REEL: 035820 FRAME: 0239. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY INTEREST RELEASE. Recorded Nov 9, 2017
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
Reel/Frame 044727/0529 →
SECURITY AGREEMENT Recorded Aug 7, 2015
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; DIRECT RADIOGRAPHY CORP.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 036307/0199 →
SECURITY INTEREST RELEASE REEL/FRAME 028810/0745 Recorded Jun 4, 2015
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
Reel/Frame 035820/0239 →
SECURITY AGREEMENT Recorded Aug 1, 2012
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
To: GOLDMAN SACHS BANK USA
Reel/Frame 028810/0745 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 27, 2010
From: MEDICAL BIOSYSTEMS LIMITED
To: REJUVIGEN LIMITED
Reel/Frame 024896/0283 →
CHANGE OF NAME Recorded Aug 27, 2010
From: REJUVIGEN LIMITED
To: MOBIOUS BIOSYSTEMS LIMITED
Reel/Frame 024896/0336 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 27, 2010
From: MOBIOUS BIO SYSTEMS LIMITED
To: GEN-PROBE INCORPORATED
Reel/Frame 024896/0309 →
Priority Claims (1)
GB 0317343.2 · Jul 24, 2003 · national
Continuity (2)
Continuation 10565750
Related Publication 20100279288A1 · Nov 4, 2010